StreetInsider.com News Articles

Form 8-K Vivani Medical, Inc. For: Aug 17

Mon, 17 Aug 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20260817/26935120.html

Form 8-K Vivani Medical, Inc. For: Aug 17

Mon, 17 Aug 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20260817/26935120.html

Form 8-K Vivani Medical, Inc. For: Aug 13

Thu, 13 Aug 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260813/26921931.html

Form 8-K Vivani Medical, Inc. For: Aug 13

Thu, 13 Aug 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260813/26921931.html

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

Thu, 13 Aug 2026 16:05:00 -0400

All participants successfully dosed in SLIM-1™, the Company's first-in-human Phase 1 trial of NPM-139, a miniature, ultra long-acting semaglutide implant for chronic weight management; top-line data expected in November 2026

Company entered into non-exclusive agreement with Novo Nordisk to evaluate NPM-139 and Vivani's proprietary NanoPortal™ technology

Completion of the Cortigent-ClearOne merger into Cortigent Holdings and initiation of trading on the Nasdaq exchange under ticker symbol CRGT anticipated in the third quarter of 2026

ALAMEDA, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a clinical-stage

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

Thu, 13 Aug 2026 16:05:00 -0400

Company entered into non-exclusive agreement with Novo Nordisk to evaluate NPM-139 and Vivani's proprietary NanoPortal™ technology

Completion of the Cortigent-ClearOne merger into Cortigent Holdings and initiation of trading on the Nasdaq exchange under ticker symbol CRGT anticipated in the third quarter of 2026

ALAMEDA, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a clinical-stage

Form 10-Q Vivani Medical, Inc. For: Jun 30

Thu, 13 Aug 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260813/26920593.html

Form 10-Q Vivani Medical, Inc. For: Jun 30

Thu, 13 Aug 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260813/26920593.html

Form 8-K Vivani Medical, Inc. For: Aug 06

Thu, 06 Aug 2026 08:15:00 -0400

si-local-file:///var/storage/secattach/20260806/26879522.html

Form 8-K Vivani Medical, Inc. For: Aug 06

Thu, 06 Aug 2026 08:15:00 -0400

si-local-file:///var/storage/secattach/20260806/26879522.html

Vivani Medical completes dosing of all SLIM-1 trial participants

Thu, 06 Aug 2026 08:00:12 -0400

Vivani Medical, Inc. (Nasdaq: VANI) announced the completion of initial dosing for all 20 participants in its SLIM-1 Phase 1 clinical trial evaluating NPM-139, a miniature subdermal semaglutide implant designed for chronic weight management.

The trial, conducted in Australia, enrolled 20 GLP-1 naïve participants who are overweight or obese but otherwise healthy. Ten participants received a low dose of NPM-139, and ten received the starting dose of Wegovy (0.25mg/week semaglutide injection). The first group was dosed on July 29, ahead of schedule, with the remaining participants dosed one week later.

NPM-139 uses Vivani's proprietary NanoPortal technology and is designed to deliver semaglutide

Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Thu, 06 Aug 2026 08:00:00 -0400

Dosing of the first participant commenced ahead of schedule and was rapidly followed by initial dosing in all trial participants.

SLIM-1™ trial is a Phase 1, randomized, controlled clinical trial design to characterize the safety, tolerability, and pharmacokinetics of NPM-139 including a Wegovy® (semaglutide injection) group.

Top-line data from the 20-participant trial is expected in November of 2026.

ALAMEDA, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) today announced full enrollment and successful initial dosing of all participants in its SLIM-1™ Phase 1 trial for

Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Thu, 06 Aug 2026 08:00:00 -0400

Dosing of the first participant commenced ahead of schedule and was rapidly followed by initial dosing in all trial participants.

Top-line data from the 20-participant trial is expected in November of 2026.

Form 4 Vivani Medical, Inc. For: Jul 28 Filed by: Dwyer Donald

Thu, 30 Jul 2026 20:28:00 -0400

si-local-file:///var/storage/secattach/20260730/26845210.html

Form 4 Vivani Medical, Inc. For: Jul 28 Filed by: Dwyer Donald

Thu, 30 Jul 2026 20:28:00 -0400

si-local-file:///var/storage/secattach/20260730/26845210.html

Form 4 Vivani Medical, Inc. For: Jul 28 Filed by: Baldor Anthony

Thu, 30 Jul 2026 20:27:00 -0400

si-local-file:///var/storage/secattach/20260730/26845208.html

Form 4 Vivani Medical, Inc. For: Jul 28 Filed by: Baldor Anthony

Thu, 30 Jul 2026 20:27:00 -0400

si-local-file:///var/storage/secattach/20260730/26845208.html

Form 4 Vivani Medical, Inc. For: Jul 28 Filed by: Porter Lisa Ellen

Thu, 30 Jul 2026 20:27:00 -0400

si-local-file:///var/storage/secattach/20260730/26845209.html

Form 4 Vivani Medical, Inc. For: Jul 28 Filed by: Porter Lisa Ellen

Thu, 30 Jul 2026 20:27:00 -0400

si-local-file:///var/storage/secattach/20260730/26845209.html

Form 4 Vivani Medical, Inc. For: Jul 28 Filed by: Mendelsohn Adam

Thu, 30 Jul 2026 20:25:00 -0400

si-local-file:///var/storage/secattach/20260730/26845206.html

Form 4 Vivani Medical, Inc. For: Jul 28 Filed by: Mendelsohn Adam

Thu, 30 Jul 2026 20:25:00 -0400

si-local-file:///var/storage/secattach/20260730/26845206.html

Form 4 Vivani Medical, Inc. For: Jul 28 Filed by: Le Truc

Thu, 30 Jul 2026 20:25:00 -0400

si-local-file:///var/storage/secattach/20260730/26845207.html

Form 4 Vivani Medical, Inc. For: Jul 28 Filed by: Le Truc

Thu, 30 Jul 2026 20:25:00 -0400

si-local-file:///var/storage/secattach/20260730/26845207.html

Form 4 Vivani Medical, Inc. For: Jul 27 Filed by: BRADBURY DANIEL

Tue, 28 Jul 2026 18:48:00 -0400

si-local-file:///var/storage/secattach/20260728/26828569.html

Form 4 Vivani Medical, Inc. For: Jul 27 Filed by: BRADBURY DANIEL

Tue, 28 Jul 2026 18:48:00 -0400

si-local-file:///var/storage/secattach/20260728/26828569.html